NEWS

Cromos™ Pharma shares its experience with clinical trials in Kazakhstan in Applied Clinical Trials Cromos™ Pharma has published an article on Clinical trials in Kazakhstan in Applied Clinical Trials journal. The company has recently initiated 3 late stage trials and the article describes its experience with the emphasis on the regulatory approval process. Please follow this link to access the article.

Cromos Pharma begins operations in Kazakhstan

cromos-pharma-at-the-swiss-biotech-day-in-basel-on-4-may-2017

Cromos™ Pharma has published a white paper on the new EU clinical trial regulation (no. 536/2014) and investigator-led studies We are glad to share with you our new white paper by Cromos™ Pharma’s VP, International Business & Operations Dr. Gearóid Tuohy regarding a new Clinical Trial Regulation (Regulation [EU] No 536/2014), scheduled for application this year, and its potential impact on the current imbalances in clinical trials. Please follow the link link to the

Cromos™ Pharma received regulatory approval for the first ever ophthalmological clinical trial in Georgia Tbilisi, Georgia. February 21, 2017. On February 17, 2017 the State Regulation Agency for Medical Activities, Ministry of Labour, Health and Social Affairs of Georgia granted Cromos™ Pharma approval to conduct the very first ophthalmology trial in Georgia. This international Phase III study in patients with Dry Eye Disease will enroll patients at 3 specialized

Cromos Pharma has published a white paper that gives a comprehensive overview of clinical trial landscape in the Republic of Georgia, which is becoming a very attractive location for clinical trials